Turmeric

DB14276ApprovedInvestigational

Turmeric is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Mechanism: Pharmacologically active on Inhibitor of nuclear factor kappa-B kinase subunit beta and Nuclear factor NF-kappa-B
Curator reviewed
First approval: Canada, 1998
Also known as: Amomum Curcuma Root · Constrained Metal (Curcuma Longa) · Curcuma Brog Root · Curcuma Domestica Extract · Curcuma Domestica Root

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

49Clinical trialsPhase, status and sponsor resolved per trial

3Structured indicationsCondition, population, route and combination as fields, not prose

32Marketed productsAcross 5 countries and 16 labellers

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Turmeric, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.